Literature DB >> 11706320

Infertility in men with cystic fibrosis.

R Z Sokol1.   

Abstract

The majority of men with cystic fibrosis (CF) have associated congenital bilateral absence of the vas deferens (CBVAD). This congenital defect results in the absence of the anatomic ducts through which spermatozoa pass from the testes to the urethra. No spermatozoa are found in the semen, a condition referred to as obstructive azoospermia. This abnormality of the genital-urinary system is associated with the same genetic mutation in the cystic fibrosis transmembrane conductance regulator gene (CFTR ), which leads to the classic presentation of a patient with CF. However, patients may have CBVAD and CFTR mutations without symptoms of CF. Screening for the common mutations may miss a milder rare gene alteration: a DNA variant in the 5T allele. With the advent of assisted reproductive technologies, fertility is now possible for these men. The National Institutes of Health recommend genetic counseling for any couple attempting assisted reproductive techniques when the man has CF or presents with obstructive azoospermia and is positive for a CF mutation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11706320     DOI: 10.1097/00063198-200111000-00011

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  8 in total

1.  Slc26a6 regulates CFTR activity in vivo to determine pancreatic duct HCO3- secretion: relevance to cystic fibrosis.

Authors:  Youxue Wang; Abigail A Soyombo; Nikolay Shcheynikov; Weizhong Zeng; Michael Dorwart; Christopher R Marino; Philip J Thomas; Shmuel Muallem
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

Review 2.  Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?

Authors:  E K Schneider; F Reyes-Ortega; J Li; T Velkov
Journal:  Clin Pharmacol Ther       Date:  2016-11-23       Impact factor: 6.875

3.  Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency.

Authors:  L Foppiani; M Baffico; G Lando; C Cappi; P De Cassan; M C Patrosso; A Vitali; S Penco; M Giusti; F Minuto
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

4.  Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

Authors:  Philip M Farrell; Beryl J Rosenstein; Terry B White; Frank J Accurso; Carlo Castellani; Garry R Cutting; Peter R Durie; Vicky A Legrys; John Massie; Richard B Parad; Michael J Rock; Preston W Campbell
Journal:  J Pediatr       Date:  2008-08       Impact factor: 4.406

5.  Gating of CFTR by the STAS domain of SLC26 transporters.

Authors:  Shigeru B H Ko; Weizhong Zeng; Michael R Dorwart; Xiang Luo; Kil Hwan Kim; Linda Millen; Hidemi Goto; Satoru Naruse; Abigail Soyombo; Philip J Thomas; Shmuel Muallem
Journal:  Nat Cell Biol       Date:  2004-03-28       Impact factor: 28.824

6.  Coupling modes and stoichiometry of Cl-/HCO3- exchange by slc26a3 and slc26a6.

Authors:  Nikolay Shcheynikov; Youxue Wang; Meeyoung Park; Shigeru B H Ko; Michael Dorwart; Satoru Naruse; Philip J Thomas; Shmuel Muallem
Journal:  J Gen Physiol       Date:  2006-04-10       Impact factor: 4.086

7.  Analysis of multiple gene co-expression networks to discover interactions favoring CFTR biogenesis and ΔF508-CFTR rescue.

Authors:  Matthew D Strub; Long Gao; Kai Tan; Paul B McCray
Journal:  BMC Med Genomics       Date:  2021-10-30       Impact factor: 3.622

Review 8.  Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.

Authors:  Matthew D Strub; Paul B McCray
Journal:  Genes (Basel)       Date:  2020-05-13       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.